Advent Health Orlando is a clinical research site located in Orlando, Florida, United States 32803.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Advent Health Orlando has participated in 43 clinical trials with 22 currently active.
Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.
Sponsors: Longboard Pharmaceuticals, Thrombolex, Inc., Novartis Pharmaceuticals.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Advent Health Orlando has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Advent Health Orlando has 43 clinical trials on record, with 22 currently active. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.
Yes — Advent Health Orlando holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.